Edit
The next generation in infection biology – Course and Conference Office

EMBL Conference

The next generation in infection biology

Overview

Conference Overview

Infectious diseases are among the most prevalent causes of human illness and death in the world. Pathogens infect humans and all life forms on Earth, being able to cross species barriers, thereby adversely impacting human and planetary health. Fundamental research in Infection Biology is urgently needed to find therapies for longstanding and emerging infectious diseases. 

The EMBL Conference: The Next Generation in Infection Biology is a platform for late-stage postdoctoral scientists in the field of infection biology to present their work and connect with the leading European institutions in infection biology. The speakers will be chosen for their track record of research accomplishments and their high-reaching future plans. The audience will have the unique opportunity to experience cutting-edge science presented by the rising leaders in this field. The institutional partners will provide discussion and networking opportunities to connect and shape the future league of infection biologists in Europe.

Session Topics

  • Host-pathogen interactions
  • Host and pathogen machineries and infection pathways
  • Host genetics and immunology
  • Clinical studies and pathogenesis
  • Vaccines and antimicrobials
  • Epidemiology modelling and open data platforms

Organisers

Scientific Organisers

Conference Organiser

Inna Boesselmann

EMBL Heidelberg

Germany

Raili Pall

EMBL Heidelberg

Germany

Participating Organisations

Please find below a list of participating institutes and universities, with more to be confirmed in the coming weeks.

Institutes / UniversitiesCountrySpokesperson
APC Microbiome Ireland, University College of CorkIrelandColin Hill
Aix-Marseille University (CNRS), Institut de Microbiologie de la Méditerranée (IMM)FranceTâm Mignot
Biozentrum, University of Basel SwitzerlandUrs Jenal
Center for Integrative Infectious Disease Research (CIID), Heidelberg UniversityGermanyFriedrich Frischknecht, Hans-Georg Kräusslich
Center of Excellence for Virus Immunology and Vaccines (CERVirVac)CroatiaStipan Jonjić
de Duve Institute, Université Catholique de LouvainBelgiumJean-François Collet
DTU BioengineeringDenmarkLars Jelsbak
EMBL AustraliaAustraliaDavid Lynn
EMBLGermany, France, Spain, UKScientific Organisers
Global Health Institute, EPFLSwitzerlandBruno Lemaitre
Helmholtz Centre for Infection Research (HZI)GermanyDirk Heinz
Hubrecht InstituteNetherlandsJeroen den Hertog
Human TechnopoleItaly
Hungarian Centre of Excellence for Molecular Medicine (HCEMM)HungaryMónika Domoki
Imperial College London, The MRC Center for Molecular Bacteriology & InfectionUKJosé Penades
Institut PasteurFrance
Institute Gulbenkian de Ciência (IGC)PortugalKarina Xavier
Institute of Microbiology, ETH ZurichSwitzerlandWolf-Dietrich Hardt
Institute of Molecular Biology and Biotechnology of the Foundation for Research and Technology Hellas (IMBB-FORTH)GreeceGeorgios Chamilos
Instituto de Medicina Molecular (iMM)PortugalMaria Mota
Institute of Technology, University of TartuEstoniaTanel Tenson
International Institute of Molecular and Cell Biology in Warsaw, (IIMCB)PolandGracjan Michlewski
Karolinska InstitutetSwedenBirgitta Henriques-Normark
LCSB, Luxembourg Centre for Systems Biomedicine, University of LuxembourgLuxembourgPaul Wilmes
Max Perutz LabsAustriaPavel Kovarik
NCRR-AntiresistSwitzerlandChristoph Dehio
CSIC, CNB – National Centre for BiotechnologySpainDaniel Lopez
Tampere University of Applied Sciences (TAMK), Tampere UniversityFinlandMataleena Parikka
The Francis Crick InstituteUKDavid Bauer
The Laboratory for Molecular Infection Medicine Sweden (MIMS), Umeå UniversitySwedenOliver Billker
The University of ToulouseFranceOlivier Neyrolles
UiT – The Arctic University of Norway, Center for New Antibacterial Strategies (CANS)NorwayPål Jarle Johnsen
UMC, Utrecht Infection & ImmunityThe NetherlandsSuzan Rooijakkers
University College DublinIrelandStephen Gordon
University of MaltaMaltaJoseph Borg
VIBBelgium
Vilnius University Life Sciences CenterLithuaniaVirgis Šikšnys
Weizmann Institute of ScienceIsraelEran Elinav

Preliminary Programme

Day 1 – Wednesday, 26 January 2022
TimeSpeaker
13:30 – 13:40 Opening remarks by Scientific Organisers
AVAILABLE ON DEMAND AFTER LIVE STREAM
13:40 – 14:20Keynote 1
14:20 – 14:25Session 1: Pathogen Biology
Chairs: tbc
14:25 – 14:45Selected Talk 1
14:45 – 15:05Selected Talk 2
15:05 – 15:25Selected Talk 3
15:25 – 15:45Selected Talk 4
15:45 – 16:05Break
16:05 – 17:05Networking Sessions with Institute Spokesperson in breakout rooms
17:05 – 17:10Session 2: Host-pathogen Interfaces
Chairs: tbc
17:10 – 17:30Selected Talk 5
17:30 – 17:50Selected Talk 6
17:50 – 18:10Selected Talk 7
18:10 – 18:30Selected Talk 8
18:30 – 18:50Break
18:50 – 19:50Networking Sessions with Institute Spokesperson in breakout rooms
End of day 1 – Continued access to networking and discussion platforms
Day 2 – Thursday, 27 January 2022
TimeSpeaker
11:00 – 12:15Career Workshop
Rachel Graf and Patricia Cabezas
12:15 – 13:30Break
13:30 – 13:40 Introduction remarks
13:40 – 14:20Keynote 2
14:20 – 14:25Session 3: Host genetics and immunology
Chairs: tbc
14:25 – 14:45Selected Talk 9
14:45 – 15:05Selected Talk 10
15:05 – 15:25Selected Talk 11
15:25 – 15:45Selected Talk 12
15:45 – 16:05Break
16:05 – 17:05Networking Sessions with Institute Spokesperson in breakout rooms
17:05 – 17:10Session 4: Anti-infectives
Chairs: tbc
17:10 – 17:30Selected Talk 13
17:30 – 17:50Selected Talk 14
17:50 – 18:10Selected Talk 15
18:10 – 18:30Selected Talk 16
18:30 – 18:50Break – Transition
18:50 – 19:50Networking Sessions with Institute Spokesperson in breakout rooms
19:50 – 20:00Closing remarks

Practical Information

Registration Fees and Abstract Submission

Registration Fees (include access to all of the talks, digital poster sessions and online group discussions, and help us cover our costs to run the event. For further information please refer to the FAQ page):

PhD Student/Postdoc140 Euro
Academia/PI190 Euro
Industry240 Euro
EMBL StaffIntranet access

Accredited journalists may be eligible to register for complimentary registration. Registrants may be required to provide accreditation or equivalent proof of press membership after registration. Please contact Inna Bösselmann for more information.

Confirmation and Payment

Registration will be on a first-come-first-served basis. Your place can only be confirmed after payment of the registration fee.
Types of payments accepted are international bank transfers and credit card payments.

Abstract Submission

Instructions for Postdocs wishing to apply for an oral presentation

Only registered participants are eligible to submit an abstract. We only accept online abstract submissions.

After you have logged in and successfully registered, you will receive an email asking you to submit your abstract of your current work, general directions of your future lab, specific aims of your research plan, and include a brief CV with three selected publications. Additionally you will be asked to submit a 5 minutes video short talk.  Click on the link provided and enter your application details. Alternatively, you can submit your abstract by clicking on the link on the confirmation page directly after registering. Your application will only be complete when both, abstract and short talk video, have been submitted. Plenary talks will be selected from the applications based on all submitted material. The submitted application material will be accessible to all participants throughout the conference.

A selection process will take place with the results announced 5-6 weeks after the abstract submission deadline.

For infection biology institutes wishing to participate, please contact the organisers.

Financial Assistance

Registration Fee Waivers

All academic and student registrants are invited to apply for a registration fee waiver, provided by the EMBL Advanced Training Centre Corporate Partnership Programme and EMBO. The registration fee waiver covers the registration sum that you have paid to attend the meeting. Conference participants are not required to pre-pay the registration fee to be selected for a fee waiver for a virtual meeting. If you have already paid the registration fee and are awarded a fee waiver, it will be reimbursed after the meeting.

Application

Applications for financial assistance can be submitted via the submission portal* (for the submission of abstracts for conferences or the submission of motivation letters for courses) by completing the Financial Assistance Application Section (underneath the section for entering abstract/motivation letter information). The link to the portal can be found in the registration confirmation email that you will receive after registering for the conference.

Selection

The scientific organisers will select the recipients of registration fee waivers during the abstract selection process for conferences and the participant selection process for courses. Results will be announced approximately 3 – 4 weeks before the event start date. Selection results do not impact your admission to the meeting. Registration fee waiver selection is based on your current work or study location, your motivation for applying, the reasons for needing financial support and the impact this event will have on your career.

Further details

Check our list of external funding opportunities and information on attending a conference as an event reporter.

For further information about financial assistance please refer to the FAQ page.

Virtual Participation Guidelines


Guidelines

Please do:

  • Use the event-specific hashtag as communicated during the event for any related tweets
  • Tweet unless the speaker specifically says otherwise
  • Be mindful of unpublished data
  • Be respectful in tone and content

Please don’t:

  • Share Slack, live stream or poster session links with others
  • Broadcast the conference to unregistered participants
  • Capture, transmit or redistribute data presented at the meeting unless presenter gives explicit consent
  • Use offensive language in your posts
  • Engage in rudeness or personal attacks

Additional information can be found in our Code of Conduct.

Health and well-being

It is important to stay healthy and move around, especially when you are attending an event virtually. We have put together a few coffee break stretches and yoga videos. You can find these under ‘resources’ on the conference platform.

How to ask questions

Please use the Q&A function. It is possible to send a direct message to participants, poster presenters, and speakers within the conference platform.

If you have any other questions, you can go to the Help Desk on the conference platform. Click on ‘more’ on the top menu and click Help Desk. 

Time zone

The programme is planned based on Central European Time (CET) or Central European Summer Time (CEST) unless otherwise stated. As many virtual participants are attending from around the world, we do our best to accommodate as many time zones as possible when creating the programme. Please take your time zone into consideration when planning your attendance. Remember to set your time zone in your account. 

Virtual event platforms

We are using a virtual event platform for this conference. More information about the platform will be shared ahead of the conference.

Sponsors

Sponsorship Opportunities

We offer a variety of event sponsoring possibilities, with the flexibility to select a set sponsorship package or combine individual sponsorship options to suit your event budget. Discounts are available for companies sponsoring multiple events at EMBL Heidelberg. View other conferences, or contact sponsorship@embl.de for further information.

If you are interested in becoming a media partner of this event, please visit our media partnerships webpage.

Date: 26 - 27 Jan 2022

Location: Virtual


Deadline(s):

Abstract submission: 3 Nov 2021

Registration: 15 Dec 2021


Organisers:

  • Pedro Beltrao
    EMBL-EBI Hinxton, UK
    • Maria Bernabeu
      EMBL Barcelona, Spain

EMBL Courses and Conferences are kindly supported by our Corporate Partnership Programme

Founder partners

Corporate partners

Associate partners

Edit